Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF Stroke Prophylaxis

Ashley Darlington1,2, Mark D McCauley1,2,3

  • 1Division of Cardiology, Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.

Insights

Atrial fibrillation (AF) increases stroke risk due to blood stasis, endothelial damage, and hypercoagulability. Atrial cardiomyopathy, causing blood stasis, is an understudied cause of AF-related stroke.

Area of Science:

  • Cardiology
  • Neurology
  • Thrombosis

Background:

  • Atrial fibrillation (AF) is a major cause of stroke, leading to high mortality and disability.
  • Stroke in AF patients is linked to Virchow's triad: blood stasis, endothelial damage, and hypercoagulability.
  • Current therapies target endothelial damage and hypercoagulability, but stroke risk persists.

Purpose of the Study:

  • To review evidence linking atrial cardiomyopathy to stroke in AF patients.
  • To explore atrial hypocontractility as a cause of blood stasis in AF.
  • To highlight the need for further research into atrial cardiomyopathy's role in AF-related stroke.

Main Methods:

  • Review of molecular, translational, and clinical studies.
  • Analysis of evidence supporting atrial cardiomyopathy as a stroke mechanism.
  • Evaluation of the role of atrial hypocontractility and blood stasis.

Main Results:

  • Atrial fibrillation satisfies all criteria of Virchow's triad.
  • Atrial hypocontractility contributes to blood stasis within the atrium.
  • Atrial cardiomyopathy is an emerging concept explaining residual stroke risk in AF.

Conclusions:

  • Atrial cardiomyopathy is a significant, under-addressed cause of stroke in atrial fibrillation.
  • Understanding atrial hypocontractility is crucial for developing new stroke prevention strategies.
  • Further investigation into atrial cardiomyopathy is warranted to reduce AF-related stroke burden.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
344
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
375
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
367
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
123
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
297
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
418